These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38177043)

  • 1. Pre-Transplant Seroprevalence, Associated Factors, and Post-Transplant Incidence of Toxoplasma gondii Infection Among Heart Transplant Recipients in Japan.
    Kanno Y; Okamoto K; Shinohara T; Kinoshita O; Hatano M; Ikeda M; Harada S; Okugawa S; Moriya K; Ono M; Tsutsumi T
    Transplant Proc; 2024; 56(1):148-152. PubMed ID: 38177043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma Gondii Serostatus in Heart Transplant Recipients: Is It an Independent Prognostic Factor?
    Barge-Caballero E; Barbeito-Caamaño C; Barge-Caballero G; Couto-Mallón D; Paniagua-Martín MJ; Marzoa-Rivas R; Solla-Buceta M; Estévez-Cid F; Herrera-Noreña JM; Cuenca-Castillo JJ; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1160-1166. PubMed ID: 27597125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serologic status of Toxoplasma gondii infection in pre- and post-heart transplantation in a pediatric population: A preliminary study.
    Orang E; Sayyahfar S; Mahdavi M; Khanaliha K; Amiri M
    Transpl Infect Dis; 2020 Aug; 22(4):e13339. PubMed ID: 32445414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Toxoplasma gondii serostatus does not affect long-term survival of cardiac transplant recipients. Analysis of the Spanish Heart Transplantation Registry.
    Barge-Caballero E; Almenar-Bonet L; Crespo-Leiro MG; Brossa-Loidi V; Rangel-Sousa D; Gómez-Bueno M; Farrero-Torres M; Díaz-Molina B; Delgado-Jiménez J; Martínez-Sellés M; López-Granados A; De-la-Fuente-Galán L; González-Costello J; Garrido-Bravo IP; Blasco-Peiró T; Rábago-Juan-Aracil G; González-Vílchez F
    Int J Cardiol; 2018 Jan; 250():183-187. PubMed ID: 29031991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis.
    Gourishankar S; Doucette K; Fenton J; Purych D; Kowalewska-Grochowska K; Preiksaitis J
    Transplantation; 2008 Apr; 85(7):980-5. PubMed ID: 18408578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide study.
    Czyzewski K; Fraczkiewicz J; Salamonowicz M; Pieczonka A; Zajac-Spychala O; Zaucha-Prazmo A; Gozdzik J; Styczynski J
    Folia Parasitol (Praha); 2019 Nov; 66():. PubMed ID: 31823860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience.
    Slavin MA; Meyers JD; Remington JS; Hackman RC
    Bone Marrow Transplant; 1994 May; 13(5):549-57. PubMed ID: 8054907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.
    Robert-Gangneux F; Meroni V; Dupont D; Botterel F; Garcia JMA; Brenier-Pinchart MP; Accoceberry I; Akan H; Abbate I; Boggian K; Bruschi F; Carratalà J; David M; Drgona L; Djurković-Djaković O; Farinas MC; Genco F; Gkrania-Klotsas E; Groll AH; Guy E; Hirzel C; Khanna N; Kurt Ö; Junie LM; Lazzarotto T; Len O; Mueller NJ; Munoz P; Pana ZD; Roilides E; Stajner T; van Delden C; Villena I; Pelloux H; Manuel O
    Emerg Infect Dis; 2018 Aug; 24(8):1497-1504. PubMed ID: 30014843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.
    Walle F; Kebede N; Tsegaye A; Kassa T
    Parasit Vectors; 2013 Jan; 6(1):15. PubMed ID: 23324409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of toxoplasmosis in transplant recipients: an update.
    Dard C; Marty P; Brenier-Pinchart MP; Garnaud C; Fricker-Hidalgo H; Pelloux H; Pomares C
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):447-460. PubMed ID: 29855213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review.
    Kitahara M; Hiroshima Y; Norose K; Hikosaka K; Kazumoto H; Uematsu N; Shishido T; Kaiume H; Sato K; Ueki T; Sumi M; Watanabe M; Kobayashi H
    Transpl Infect Dis; 2021 Dec; 23(6):e13726. PubMed ID: 34542220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Toxoplasma gondii among pregnant women attending antenatal clinics at Hawassa University comprehensive specialized and Yirgalem General Hospitals, in Southern Ethiopia.
    Fenta DA
    BMC Infect Dis; 2019 Dec; 19(1):1056. PubMed ID: 31842783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality.
    Arora S; Jenum PA; Aukrust P; Rollag H; Andreassen AK; Simonsen S; Gude E; Fiane AE; Geiran O; Gullestad L
    J Am Coll Cardiol; 2007 Nov; 50(20):1967-72. PubMed ID: 17996562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis.
    Minbaeva G; Schweiger A; Bodosheva A; Kuttubaev O; Hehl AB; Tanner I; Ziadinov I; Torgerson PR; Deplazes P
    PLoS Negl Trop Dis; 2013; 7(2):e2043. PubMed ID: 23409201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach.
    Aerts R; Mercier T; Beckers M; Schoemans H; Lagrou K; Maertens J
    Clin Microbiol Infect; 2022 Mar; 28(3):440-445. PubMed ID: 34634458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.
    Adekunle RO; Sherman A; Spicer JO; Messina JA; Steinbrink JM; Sexton ME; Lyon GM; Mehta AK; Phadke VK; Woodworth MH
    Transpl Infect Dis; 2021 Aug; 23(4):e13636. PubMed ID: 33993599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: Impact of serostatus-based management.
    Amikura T; Kikuchi T; Kato J; Koda Y; Sakurai M; Yamazaki R; Mikita K; Saburi M; Nakazato T; Mori T
    Transpl Infect Dis; 2021 Jun; 23(3):e13506. PubMed ID: 33174304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasmosis in the non-orthotopic heart transplant recipient population, how common is it? Any indication for prophylaxis?
    Dhakal R; Gajurel K; Montoya JG
    Curr Opin Organ Transplant; 2018 Aug; 23(4):407-416. PubMed ID: 29878911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasma infection in kidney donors and transplant recipients from Western Mexico: A one-year follow-up.
    Galván-Ramírez ML; Sánchez-Orozco LV; Andrade-Sierra J; Mendoza-Cabrera S; Evangelista-Carrillo LA; Rodríguez Pérez LR; Chiquete E; Armendáriz-Borunda J
    Transpl Infect Dis; 2019 Oct; 21(5):e13139. PubMed ID: 31271696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii Serology and Outcomes After Heart Transplantation: Contention in the Literature.
    Chehrazi-Raffle A; Luu M; Yu Z; Liou F; Kittleson M; Hamilton M; Kobashigawa J
    Transplant Proc; 2015; 47(6):1949-53. PubMed ID: 26293079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.